The stock price of Fortis Healthcare is quoting at ₹731.35, its highest level since January 8, 2025, and inching towards its record high level of ₹744, touched on December 30, 2024.
Reaffirming its commitment towards global health cooperation, India has sent a delegation to participate in the 78th World Health Assembly commencing in Geneva, the Ministry of Health and Family Welfare (MoHFW), shared on Monday.Providing the details in a post on X, the MoHFW said that the Indian delegation is being led by Punya Salila Srivastava, Secretary, Ministry of Health & Family Welfare.It further noted that India's participation reflects the continued commitment towards strengthening global health systems and advancing international collaboration."Today marks the commencement of the 78th World Health Assembly in Geneva. The Indian delegation, led by Ms. Punya Salila Srivastava, Secretary, Ministry of Health & Family Welfare, Government of India, is actively participating in the Assembly, reflecting India's continued commitment to strengthening global health systems and advancing international collaboration."As per the World Health Organisation, the 78th World ...
DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's what brokerages expect from the company going ahead
Fact check Friday: From turmeric fears to water detox delusions, leading gastroenterologist Dr Gourdas Choudhuri clears the air on widespread liver health myths
World Asthma Day 2025: As India battles rising asthma cases driven by pollution and lifestyle shifts, innovations in diagnosis, inhalers, and digital tools are redefining care
Global medtech giants like Siemens and Philips are expanding R&D and manufacturing in India, leveraging policy support and talent to embed India in global value chains
Only about eight per cent of bacterial infections detected in 2019 in India were treated appropriately, according to an analysis of low- and middle-income countries. Findings published in The Lancet Infectious Diseases journal show that in 2019, there were nearly 15 lakh bacterial infections resistant to carbapenems -- a common antibiotic -- across eight countries that were under study. Carbapenems are used for treating severe infections -- such as those acquired from being inside a hospital, where bacteria resistant to antibiotics are abundant. Of the 15 lakh bacterial infections, only over a lakh treatment courses were procured -- the resulting treatment gap meant that only 6.9 per cent of the patients were treated appropriately, researchers, including those from the Global Antibiotic Research and Development Partnership (GARDP), Switzerland, found. "India procured most of the treatment courses (80.5 per cent; 83,468 courses), with 7.8 per cent of infections treated appropriately
Endless scrolling may feel harmless, but experts warn it can erode attention span, memory, and mental clarity-here's how to recognise and reverse the damage
Tamil Nadu bans raw egg mayonnaise for a year citing risks of foodborne infections like Salmonella and broader health threats like fatty liver and obesity-related disorders
World Immunisation Week 2025: WHO's global health campaign reaffirms the power of vaccines in protecting lives and communities; here's all you need to know
Learn how to use official portals to find empanelled hospitals near you under Ayushman Bharat PM-JAY and access up to ₹5 lakh in free healthcare benefits
On World Parkinson's Day, experts highlight that cases may cross 25 million globally by 2050, urging early detection, treatment, and greater public awareness
World health day: 4 in 10 Indian households have reported purchasing infested packaged food in the past three years, reveals a new survey that paints a worrying picture of food safety in the country
Sadhguru, a well-known yogi, has provided a 30% diet challenge that would not only enhance your general health but also make you appear 20 years younger than you actually are. Here are some insights
Private players say lower rates, delayed dues hampering participation in the scheme
Mounjaro, Eli Lilly's diabetes and obesity drug, is now available in India at a fraction of its US price. It offers treatment for weight loss and diabetes control, but watch out for the side effects
Many Indian doctors also find more chances to grow in their careers and get better recognition for their work abroad
Biosimilars can not only reduce patients' financial burdens, but also encourage more people to go for early diagnosis and comprehensive treatment
Supreme Court calls for policy to stop hospitals from forcing patients to buy medicines, medical devices at high rates from hospital-linked pharmacies, asks states to regulate pricing
Narayana Hrudayalaya management remains confident that the new hospital will become a strong engine of growth in Cayman over the next few years.